drugset / Trial / NCT00487656
Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to see if ART-123 (recombinant human soluble thrombomodulin) decreases the number of people who die as a result of Disseminated Intravascular Coagulation (DIC) complication of sepsis.
Timeline
- Start
- 2007-07
- Primary completion
- 2010-05
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | thrombomodulin alfa | Protein / enzyme biologic | 0.01 mg/kg | — |